Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Evolus (NASDAQ:EOLS) through any online brokerage.
Other companies in Evolus’s space includes: Atea Pharmaceuticals Inc (NASDAQ:AVIR), MediWound Ltd (NASDAQ:MDWD), Zevra Therapeutics Inc (NASDAQ:ZVRA), SNDL Inc (NASDAQ:SNDL) and NervGen Pharma Corp (NASDAQ:NGEN).
Evolus has a consensus price target of $17.50.
The stock price for Evolus (NASDAQ: EOLS) is $5.31 last updated April 24, 2026 at 9:30 AM EDT.
There are no upcoming dividends for Evolus.
Evolus does not have any upcoming earnings scheduled.
There is no upcoming split for Evolus.
Evolus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.